Seven-Year Follow-up of Patients Diagnosed with Atypical Odontalgia: A Prospective Study

Aims: To examine the long-term prognosis of 46 previously examined atypical odontalgia (AO) patients. Methods: In 2002 and 2009, AO patients completed validated instruments measuring pain characteristics (pain frequency and intensity), physical functioning (Graded Chronic Pain Severity, GCPS) and emotional functioning (Symptoms Checklist, SCL-90R). The main outcome was global improvement. Baseline data on quantitative somatosensory testing and responsiveness to lidocaine injection were available for a subgroup of patients. Paired tests compared baseline and follow-up data, and logistic regression explored the possible prognostic value of baseline data. Results: Data from 37 patients (80%) were obtained. Thirteen patients (35%; 95% confidence intervals [CI] 20.2%-52.5%) rated their overall pain status as significantly improved, 22 (60%; 95% CI 42.1%-75.3%) as a little improved or unchanged, and two patients (5%; 95% CI 0.7%-18.2%) as worse. Five patients (14%; 95% CI 4.5%-28.8%) were pain-free, indicated by a characteristic pain intensity score of 0. Average pain intensity decreased (from 5.7 ± 2.0 to 3.5 ± 2.4; P < .001). Pain frequency (P < .001) and GCPS (P < .001) also decreased, whereas SCL-90R scores remained unchanged and 26 of the 37 patients reported ongoing treatment. Low baseline pain intensity was the only factor predictive of favorable outcome. Conclusion: A third of the AO patients improved considerably over time, but for many of the patients, AO was a persistent and treatment-resistant condition.

neuropathic pain; orofacial pain; prognosis; prospective study; trigeminal nerve

1. aggarwal Vr, McBeth J, Zakrzewska JM, Lunt M, Macfarlane GJ. The epidemiology of chronic syndromes that are frequently unexplained: Do they have common associated factors? int J Epidemiol 2006;35:468–476.

2. Dworkin Sf, Von Korff M, Leresche L. Multiple pains and psychiatric disturbance. an epidemiologic investigation. arch Gen Psychiatry 1990;47:239–244.

3. Medicinenet.inc. www.medterms.com. Online web version of Webster’s new World Medical Dictionary, ed 3. new York: Wiley, 2008.

4. angst f, Verra ML, Lehmann S, Brioschi r, aeschlimann

a. clinical effectiveness of an interdisciplinary pain management programme compared with standard inpatient rehabilitation in chronic pain: a naturalistic, prospective controlled cohort study. J rehabil Med 2009;41:569–575.

5. navarro a, Saldana MT, Perez c, Torrades S, rejas J. Patient-reported outcomes in subjects with neuropathic pain receiving pregabalin: Evidence from medical practice in primary care settings. Pain Med 2010;11:719–731.

6. Leichsenring f. randomized controlled versus naturalistic studies: a new research agenda. Bull Menninger clin 2004;68:137–151.

7. Melis M, Lobo SL, ceneviz c, et al. atypical odontalgia: a review of the literature. Headache 2003;43:1060–1074.

8. nixdorf Dr, Drangsholt MT, Ettlin Da, et al. classifying orofacial pains: a new proposal of taxonomy based on ontology. J Oral rehabil 2012;39:161–169.

9. nixdorf Dr, Moana-filho EJ, Law aS, McGuire La, Hodges JS, John MT. frequency of nonodontogenic pain after endodontic therapy: a systematic review and meta- analysis. J Endod 2010;36:1494–1498.

10. List T, Leijon G, Helkimo M, Oster a, Dworkin Sf, Svensson

P. clinical findings and psychosocial factors in patients with atypical odontalgia: a case-control study. J Orofac Pain 2007;21:89–98.

11. Baad-Hansen L, List T, Jensen TS, Svensson P. increased pain sensitivity to intraoral capsaicin in patients with atypi cal odontalgia. J Orofac Pain 2006;20:107–114.

12. Baad-Hansen L, List T, Kaube H, Jensen TS, Svensson P. Blink reflexes in patients with atypical odontalgia and matched healthy controls. Exp Brain res 2006;172: 498–506.

13. List T, Leijon G, Helkimo M, Oster a, Svensson P. Effect of local anesthesia on atypical odontalgia–a randomized controlled trial. Pain 2006;122:306–314.

14. List T, Leijon G, Svensson P. Somatosensory abnormalities in atypical odontalgia: a case-control study. Pain 2008;139:333–341.

15. Baron r, Binder a, Wasner G. neuropathic pain: Diagnosis, pathophysiological mechanisms, and treatment. Lancet neurol 2010;9:807–819.

16. allerbring M, Hägerstam G. chronic idiopathic orofacial pain. a long-term follow-up study. acta Odontol Scand 2004;62:66–69.

17. Baad-Hansen L, Leijon G, Svensson P, List T. comparison of clinical findings and psychosocial factors in patients with atypical odontalgia and temporomandibular disorders. J Orofac Pain 2008;22:7–14.

18. Dworkin rH, Turk Dc, farrar JT, et al. core outcome measures for chronic pain clinical trials: iMMPacT recommendations. Pain 2005;113:9–19.

19. Haythornthwaite Ja. iMMPacT recommendations for clinical trials: Opportunities for the rDc/TMD. J Oral rehabil 2010;37:799–806.

20. Guy W. EcDEU assessment Manual for Psychopharmacology. rockville, MD: DHEW, 1976.

21. Dworkin Sf, Leresche L. research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J craniomandib Disord 1992;6:301–355.

22. Ohrbach r, Turner Ja, Sherman JJ, et al. The research diagnostic criteria for temporomandibular disorders. iV: Evaluation of psychometric properties of the axis ii measures. J Orofac Pain 2010;24:48–62.

23. Burckhardt cS, Bjelle a. a Swedish version of the short- form McGill Pain Questionnaire. Scand J rheumatol 1994;23:77–81.

24. Melzack r. The short-form McGill Pain Questionnaire. Pain 1987;30:191–197.

25. Ware JE Jr, Sherbourne cD. The MOS 36-item short-form health survey (Sf-36). i. conceptual framework and item selection. Med care 1992;30:473–483.

26. Ohrbach r, Larsson P, List T. The jaw functional limitation scale: Development, reliability, and validity of 8-item and 20-item versions. J Orofac Pain 2008;22:219–230.

27. Watson cP, Watt Vr, chipman M, Birkett n, Evans rJ. The prognosis with postherpetic neuralgia. Pain 1991;46: 195–199.

28. Ohrbach r, Dworkin Sf. five-year outcomes in TMD: relationship of changes in pain to changes in physical and psychological variables Pain 1998;74:315–326.

29. collins SL, Edwards J, Moore ra, Smith La, McQuay HJ. Seeking a simple measure of analgesia for megatrials: is a single global assessment good enough? Pain 2001; 91:189–194.

30. Baron r, Brunnmuller U, Brasser M, May M, Binder a. Efficacy and safety of pregabalin in patients with diabetic peripheral neuropathy or postherpetic neuralgia: Open- label, non-comparative, flexible-dose study. Eur J Pain 2008;12:850–858.

31. Bolton JE. Sensitivity and specificity of outcome measures in patients with neck pain: Detecting clinically significant improvement. Spine (Phila Pa 1976) 2004;29:2410–2417; discussion 2418.

32. Dunkl Pr, Taylor aG, Mcconnell GG, alfano aP, conaway Mr. responsiveness of fibromyalgia clinical trial outcome measures. J rheumatol 2000;27:2683–2691.

33. Emshoff r, Emshoff i, Bertram S. Estimation of clinically important change for visual analog scales measuring chronic temporomandibular disorder pain. J Orofac Pain 2010;24:262–269.

34. farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole rM. clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001;94:149–158.

35. Stone aa, Schwartz JE, Broderick JE, Shiffman SS. Variability of momentary pain predicts recall of weekly pain: a consequence of the peak (or salience) memory heuristic. Pers Soc Psychol Bull 2005;31:1340–1346.

36. Maier c, Baron r, Tolle Tr, et al. Quantitative sensory testing in the German research network on neuropathic Pain (DfnS): Somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes. Pain 2010;150:439–450.

37. rolke r, Baron r, Maier c, et al. Quantitative sensory testing in the German research network on neuropathic Pain (DfnS): Standardized protocol and reference values. Pain 2006;123:231–243.

38. Woolf cJ. central sensitization: implications for the diagnosis and treatment of pain. Pain 2011;152:S2–S15.

39. Baad-Hansen L. atypical odontalgia—Pathophysiology and clinical management. J Oral rehabil 2008;35:1–11.

40. Wiffen PJ, Derry S, Moore ra, McQuay HJ. carbamazepine for acute and chronic pain in adults cochrane Data-base Syst rev 2011;(1):cD005451.

41. Saarto T, Wiffen PJ. antidepressants for neuropathic pain: a cochrane review. J neurol neurosurg Psychiatry 2010;81:1372–1373.

42. forssell H, Tasmuth T, Tenovuo O, Hampf G, Kalso E. Ven- lafaxine in the treatment of atypical facial pain: a rand- omized controlled trial. J Orofac Pain 2004;18:131–137.

43. Vickers Er, cousins MJ, Walker S, chisholm K. analysis of 50 patients with atypical odontalgia. a preliminary report on pharmacological procedures for diagnosis and treat- ment. Oral Surg Oral Med Oral Pathol Oral radiol Endod 1998;85:24–32.

44. Wolf E, Birgerstam P, nilner M, Petersson K. Patients’ experiences of consultations for nonspecific chronic oro- facial pain: a phenomenological study. J Orofac Pain 2006;20:226–233.

45. Turk Dc, audette J, Levy rM, Mackey Sc, Stanos S. assessment and treatment of psychosocial comorbidities in patients with neuropathic pain. Mayo clin Proc 2010;85:S42–S50.

46. Wetering EJ, Lemmens KM, nieboer aP, Huijsman r. cognitive and behavioral interventions for the management of chronic neuropathic pain in adults–a systematic review. Eur J Pain 2010;14:670–681.